Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on...ASCO's Statement on the Financial Barriers to Clinical Trial Participation: With Beverly Moy, MD, Clinical Director of the Breast Oncology Program at Massachusetts General Hospital

  Sarah DiGiulio

• Free

  A Look at Receiving Concurrent Cancer Treatment & Hospice Care
• Free

  Cancers of the Gullet, Stomach & Bowel Respond to New Anti-HER2 Drug
• Free

  Circulating Tumor DNA as a Biomarker for Diffuse Large B-Cell Lymphoma

  Richard Simoneaux

• Free

  Clear Communication: Always Key to Quality Care

  Michelle Perron

• Free

  Combination of Two Immunotherapies Shows Activity in NSCLC
• Free

  Difficult-to-Treat Bowel Cancers Respond to New Drug Combination
• Free

  Drug Combination as Potential Treatment for Neuroblastoma
• Free

  Drug Matched to Cancer Patients According to Tumor Gene Testing
• Free

  How Mutations Boost Immunity Could Lead to Cancer Vaccine
• Free

  Identifying Most Effective Drugs for Breast Cancer Patients
• Free

  Immunotherapy Approach Turns Cells Into Anti-Tumor Drug Factories
• Free

  Key Signaling Pathway Could Lead to New Targets in Colorectal Cancer

  Bruce M. Boman MD, PhD, MSPH, FACP

• Free

  Let It Go

  Brian J. Bolwell MD, FACP

• Free

  NCPF Meeting Explores New Technologies in Precision Oncology

  Peggy Eastman

• Free

  New Approaches to Streamlining Cancer Drug Development

  Peggy Eastman

• Free

  New Oral Drug Boosts Radiotherapy for Hard-To-Treat Cancers
• Free

  New Tool Opens Door to Next-Gen Targeted Immunotherapies
• Free

  Olaparib (Lynparza®)

  Kendall C. Shultes PharmD

• Free

  Platform Increases Patient Access to New Treatments & Technologies

  Eric D. Whitman MD, FACS

• Free

  Promising Lead in Genetic Approach to Treating Glioblastoma
• Free

  Proposed Cancer Treatment May Boost Lung Cancer Stem Cells
• Free

  Rare, Incurable Digestive Tract Cancers Respond to New Drug Combination
• Free

  Recently Diagnosed Cancer Survivors More Likely to Drink, Smoke
• Free

  Ribociclib Plus Fulvestrant for HR+, HER2- Advanced Breast Cancer

  Francisco J. Esteva MD, PhD

• Free

  Scientists Trained a Computer to Classify Breast Cancer Tumors
• Free

  Single-Cell Sequencing Highlights Why Cancers Form in Specific Cell Types
• Free

  Some Books I've Enjoyed

  George W. Sledge MD

• Free

  Surprising Number of Americans Believe Alternative Therapies Can Cure Cancer
• Free

  The Discovery of 40 New Genetic Variants Linked to Colorectal Cancer Risk
• Free

  UpToDate®
• Buy

  Early Results for Ivosidenib in IDH1-Mutant Relapsed or Refractory AML

  Richard Simoneaux

• Buy

  Intravascular Large B-Cell Lymphoma: An Elusive Disease

  Pamela Crilley DO

• Buy

  New Clinical Trials Recently Added to the National Cancer Institute's Database
• Buy

  Shop Talk
• Buy

  Unique National Study Focuses on Rare Cancer Tumors

  Danielle Bullen Love